167 related articles for article (PubMed ID: 12186474)
21. Biophysical targeting of adenovirus vectors for gene therapy.
Silman NJ; Fooks AR
Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
[TBL] [Abstract][Full Text] [Related]
22. The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro.
Grill J; Lamfers ML; van Beusechem VW; Dirven CM; Pherai DS; Kater M; Van der Valk P; Vogels R; Vandertop WP; Pinedo HM; Curiel DT; Gerritsen WR
Mol Ther; 2002 Nov; 6(5):609-14. PubMed ID: 12409259
[TBL] [Abstract][Full Text] [Related]
23. The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells.
Kim M; Zinn KR; Barnett BG; Sumerel LA; Krasnykh V; Curiel DT; Douglas JT
Eur J Cancer; 2002 Sep; 38(14):1917-26. PubMed ID: 12204675
[TBL] [Abstract][Full Text] [Related]
24. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse.
Kalamarides M; Niwa-Kawakita M; Leblois H; Abramowski V; Perricaudet M; Janin A; Thomas G; Gutmann DH; Giovannini M
Genes Dev; 2002 May; 16(9):1060-5. PubMed ID: 12000789
[TBL] [Abstract][Full Text] [Related]
25. The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse.
Espinosa AB; Tabernero MD; Maíllo A; Sayagués JM; Ciudad J; Merino M; Alguero MC; Lubombo AM; Sousa P; Santos-Briz A; Orfao A
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):772-80. PubMed ID: 16467088
[TBL] [Abstract][Full Text] [Related]
26. Clear cell meningiomas: three case reports with genetic characterization and review of the literature.
Ohba S; Sasaki H; Kimura T; Ikeda E; Kawase T
Neurosurgery; 2010 Sep; 67(3):E870-1; discussion E871. PubMed ID: 20683214
[TBL] [Abstract][Full Text] [Related]
27. Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivo.
Seki T; Dmitriev I; Suzuki K; Kashentseva E; Takayama K; Rots M; Uil T; Wu H; Wang M; Curiel DT
Gene Ther; 2002 Aug; 9(16):1101-8. PubMed ID: 12140738
[TBL] [Abstract][Full Text] [Related]
28. Transductional targeting of adenovirus vectors for gene therapy.
Glasgow JN; Everts M; Curiel DT
Cancer Gene Ther; 2006 Sep; 13(9):830-44. PubMed ID: 16439993
[TBL] [Abstract][Full Text] [Related]
29. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
Tolmachov OE
Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
[TBL] [Abstract][Full Text] [Related]
30. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.
Haviv YS; Blackwell JL; Kanerva A; Nagi P; Krasnykh V; Dmitriev I; Wang M; Naito S; Lei X; Hemminki A; Carey D; Curiel DT
Cancer Res; 2002 Aug; 62(15):4273-81. PubMed ID: 12154029
[TBL] [Abstract][Full Text] [Related]
31. Novel adenoviral gene delivery system targeted against head and neck cancer.
Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
[TBL] [Abstract][Full Text] [Related]
32. Related mechanisms, current treatments, and new perspectives in meningioma.
Inetas-Yengin G; Bayrak OF
Genes Chromosomes Cancer; 2024 May; 63(5):e23248. PubMed ID: 38801095
[TBL] [Abstract][Full Text] [Related]
33. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G
J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070
[TBL] [Abstract][Full Text] [Related]
34. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
35. Targeting of adenoviral vectors through a bispecific single-chain antibody.
Haisma HJ; Grill J; Curiel DT; Hoogeland S; van Beusechem VW; Pinedo HM; Gerritsen WR
Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
[TBL] [Abstract][Full Text] [Related]
36. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.
Peyre M; Stemmer-Rachamimov A; Clermont-Taranchon E; Quentin S; El-Taraya N; Walczak C; Volk A; Niwa-Kawakita M; Karboul N; Giovannini M; Kalamarides M
Oncogene; 2013 Sep; 32(36):4264-72. PubMed ID: 23045274
[TBL] [Abstract][Full Text] [Related]
37. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated gene transfer of dominant negative Ha-Ras inhibits proliferation of primary meningioma cells.
Shu J; Lee JH; Harwalkar JA; Oh-Siskovic S; Stacey DW; Golubić M
Neurosurgery; 1999 Mar; 44(3):579-87; discussion 587-8. PubMed ID: 10069595
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
[TBL] [Abstract][Full Text] [Related]
40. [Meningiomas: new prognostic factors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]